Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,462.80
(
0.00%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
111.72
(
-0.58%
)
Bitcoin
76,102.61
(
0.43%
)
News Focus
News Focus
Post# of 257470
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122909
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ciotera post# 215944

Tuesday, 12/12/2017 11:29:28 AM

Tuesday, December 12, 2017 11:29:28 AM

Post# of 257470

(EGRX)—Should knock out [Bendamustine/Rituxan] as the SoC in 2L if people can get over TLS.

Bearish for EGRX's Bendeka, but that product has a sell-by date of Nov 2019 in any case.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today